Prosecution Insights
Last updated: April 19, 2026

Examiner: YU, DELPHINUS DOU YI

Tech Center 1600 • Art Units: 1636 1645

This examiner grants 0% of resolved cases

Performance Statistics

%
Allow Rate
-60.0% vs TC avg
13
Total Applications
Interview Lift
1175
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

8.7%
§101 Eligibility
6.5%
§102 Novelty
32.6%
§103 Obviousness
50.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18452127 HIGH-THROUGHPUT METHODS FOR ANALYZING AND AFFINITY-MATURING AN ANTIGEN-BINDING MOLECULE Non-Final OA 10x Genomics, Inc.
18261551 IMPROVED PRODUCTION OF RECOMBINANT POLYPEPTIDES AND VIRUSES Non-Final OA REGENXBIO Inc.
18496554 Splicing Modulators for the Treatment of Timothy Syndrome Non-Final OA The Board of Trustees of the Leland Stanford Junior University
18249016 PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF RETINAL OR CHOROIDAL DISEASE COMPRISING PLVAP AS ACTIVE INGREDIENT Non-Final OA UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION
18254669 LENTIVIRAL VECTOR TECHNOLOGY FOR INNER EAR GENE THERAPY Non-Final OA Medizinische Hochschule Hannover
18457605 GENE SILENCING THERAPY OF ACUTE RESPIRATORY DISORDER Non-Final OA Therapeutic Solutions International, Inc.
18269479 APTAMERS AND USE OF THE APTAMERS IN THE DIAGNOSIS AND TREATMENT OF A SARS-COV-2 INFECTION Non-Final OA RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN
17951842 METHODS FOR PREPARING NANOPARTICLE COMPOSITIONS CONTAINING HISTIDINE-LYSINE COPOLYMERS Non-Final OA Sirnaomics, Inc.
18184721 VIRULENCE FACTOR FSPL GENE FROM SUGARCANE POKKAH BOENG DISEASE AND USE THEREOF Non-Final OA GUANGXI UNIVERSITY
15734918 LABELING OF DNA Non-Final OA Bionano Genomics, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month